Oral WGP Beta Glucan Treatment Accelerates Myeloid Recovery after Radiation Exposure. Presented at BTR 2003
doi.org
dx.doi.org
Vetvicka, V; Thornton BP; Ross GD (1 de julio de 1996). «Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells». The Journal of clinical investigation (United States: American Society for Clinical Investigation) 98 (1): 50-61. PMID8690804. doi:10.1172/JCI118777.
Sveinbjørnsson, B; Rushfeldt C, Seljelid R, Smedsrød B (mayo de 1998). «Inhibition of establishment and growth of mouse liver metastases after treatment with interferon gamma and beta-1,3-D-glucan». Hepatology (Baltimore, Md.) (United States: Wiley) 27 (5): 1241-1248. PMID9581677. doi:10.1002/hep.510270509.
Suzuki, I; Hashimoto K; Ohno N; Tanaka H; Yadomae T (1989). «Immunomodulation by orally administered beta-glucan in mice». >International journal of immunopharmacology (England: Elsevier Science) 11 (7): 761-769. PMID2599714. doi:10.1016/0192-0561(89)90130-6.
Demir, G; Klein HO, Mandel-Molinas N, Tuzuner N (enero de 2007). «Beta glucan induces proliferation and activation of monocytes in peripheral blood of patients with advanced breast cancer». International immunopharmacology (Netherlands: Elsevier Science) 7 (1): 113-116. PMID17161824. doi:10.1016/j.intimp.2006.08.011.
Dellinger, EP; Babineau TJ; Bleicher P; Kaiser AB; Seibert GB; Postier RG; Vogel SB; Norman J; Kaufman D; Galandiuk S; Condon RE (septiembre de 1999). «Effect of PGG-glucan on the rate of serious postoperative infection or death observed after high-risk gastrointestinal operations. Betafectin Gastrointestinal Study Group». Archives of surgery (Chicago, Ill. : 1960) (United States: American Medical Association) 134 (9): 977-983. PMID10487593. doi:10.1001/archsurg.134.9.977.
Patchen, ML; MacVittie TJ (abril de 1983). «Dose-dependent responses of murine pluripotent stem cells and myeloid and erythroid progenitor cells following administration of the immunomodulating agent glucan». Immunopharmacology (Netherlands: Elsevier/North-Holland) 5 (4): 303-313. PMID6853144. doi:10.1016/0162-3109(83)90046-2.
Patchen, ML; MacVittie TJ, Wathen LM (15 de noviembre de 1984). «Effects of pre- and post-irradiation glucan treatment on pluripotent stem cells, granulocyte, macrophage and erythroid progenitor cells, and hemopoietic stromal cells». Experientia (Switzerland: Birkhäuser Verlag) 40 (11): 1240-1244. PMID6500009. doi:10.1007/BF01946654.
Turnbull, JL; Patchen ML; Scadden DT (1999). «The polysaccharide, PGG-glucan, enhances human myelopoiesis by direct action independent of and additive to early-acting cytokines». Acta haematologica (Switzerland: Karger) 102 (2): 66-71. PMID10529508. doi:10.1159/000040972.
Vetvicka, V; Dvorak B; Vetvickova J; Richter J; Krizan J; Sima P; Yvin JC (10 de marzo de 2007). «Orally administered marine (1-->3)-beta-D-glucan Phycarine stimulates both humoral and cellular immunity.». International journal of biological macromolecules (England: Butterworth-Heinemann) 40 (4): 291-298. PMID16978690. doi:10.1016/j.ijbiomac.2006.08.009.
Mucksová, J; Babícek K, Pospísil M (2001). «Particulate 1,3-beta-D-glucan, carboxymethylglucan and sulfoethylglucan--influence of their oral or intraperitoneal administration on immunological respondence of mice.». Folia microbiologica (Czech Republic: Slovak Academy Of Sciences) 46 (6): 559-563. PMID11898349. doi:10.1007/BF02818003.
Cramer, DE; Allendorf DJ; Baran JT; Hansen R; Marroquin J; Li B; Ratajczak J; Ratajczak MZ et al. (15 de enero de 2006). «Beta-glucan enhances complement-mediated hematopoietic recovery after bone marrow injury». Blood (United States: American Society of Hematology) 107 (2): 835-840. PMID16179370. doi:10.1182/blood-2005-07-2705.Se sugiere usar |número-autores= (ayuda)
Sener, G; Toklu H; Ercan F; Erkanli G (agosto de 2005). «Protective effect of beta-glucan against oxidative organ injury in a rat model of sepsis». International immunopharmacology (Netherlands: Elsevier Science) 5 (9): 1387-1396. PMID15953565. doi:10.1016/j.intimp.2005.03.007.
Browder, IW; Williams DL, Kitahama A, Di Luzio NR (1984). «Modification of post-operative C. albicans sepsis by glucan immunostimulation.». International journal of immunopharmacology (England: Elsevier Science) 6 (1): 19-26. PMID6724765. doi:10.1016/0192-0561(84)90030-4.
Kogan, G; Stasko A; Bauerova K; Polovka M; Soltes L; Brezova V; Navarova J (4 de julio de 2005). «Antioxidant properties of yeast (1→3)-β-d-glucan studied by electron paramagnetic resonance spectroscopy and its activity in the adjuvant arthritis». Carbohydrate Polymers (Elsevier) 61 (1): 18-28. doi:10.1016/j.carbpol.2005.02.010.
Battilana, P; Ornstein K, Minehira K, Schwarz JM, Acheson K, Schneiter P, Burri J, Jéquier E, Tappy L (mayo de 2001). «Mechanisms of action of beta-glucan in postprandial glucose metabolism in healthy men.». European journal of clinical nutrition (England: Nature Publishing Group) 55 (5): 327-333. PMID11378805. doi:10.1038/sj.ejcn.1601160.
Tsukada, C; Yokoyama H; Miyaji C; Ishimoto Y; Kawamura H; Abo T (enero de 2003). «Immunopotentiation of intraepithelial lymphocytes in the intestine by oral administrations of beta-glucan». Cellular immunology (United States: Academic Press) 221 (1): 1-5. PMID12742376. doi:10.1016/S0008-8749(03)00061-3.
Muller, CD; Bocchini V; Giaimis J; Guerrieri P; Lombard Y; Poindron P (mayo de 1994). «Functional beta-glucan receptor expression by a microglial cell line». Research in immunology (France: Elsevier) 145 (4): 267-275. PMID7824804. doi:10.1016/S0923-2494(94)80015-4.
Bolcal, C; Bolcal C, Yildirim V, Doganci S, Sargin M, Aydin A, Eken A, Ozal E, Kuralay E, Demirkilic U, Tatar H (15 de mayo de 2007). «Protective effects of antioxidant medications on limb ischemia reperfusion injury». The Journal of surgical research (United States: Academic Press) 139 (2): 274-279. PMID17349658. doi:10.1016/j.jss.2006.10.043.
Frey, A.; Frey A, Giannasca KT, Weltzin R, Giannasca PJ, Reggio H, Lencer WI, Neutra MR (1 de septiembre de 1996). «Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting». The Journal of experimental medicine (United States: Rockefeller University Press) 184 (3): 1045-1059. PMID9064322. doi:10.1084/jem.184.3.1045.
Tsukagoshi, S; Tsukagoshi S, Hashimoto Y, Fujii G, Kobayashi H, Nomoto K, Orita K (junio de 1984). «Krestin (PSK)». Cancer treatment reviews (England: Saunders) 11 (2): 131-155. PMID6238674. doi:10.1016/0305-7372(84)90005-7.
Obayashi T, Yoshida M, Mori T, et al. (1995). «Plasma (13)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes». Lancet345: 17-20. doi:10.1016/S0140-6736(95)91152-9.
Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. (2005). «Multicenter clinical evaluation of the (1→3)β-D-glucan assay as an aid to diagnosis of fungal infections in humans». Clin Infect Dis41: 654-659. doi:10.1086/432470.
Odabasi Z, Mattiuzzi G, Estey E, et al. (2004). «Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome». Clin Infect Dis39: 199-205. doi:10.1086/421944.
Wasser, SP; Weis AL (1999). «Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective». Critical reviews in immunology (United States: Begell House) 19 (1): 65-96. ISSN1040-8401. PMID9987601.
Miura, NN; Ohno N; Aketagawa J; Tamura H; Tanaka S; Yadomae T (enero de 1996). «Blood clearance of (1-->3)-beta-D-glucan in MRL lpr/lpr mice». FEMS immunology and medical microbiology (England: Blackwell Publishing) 13 (1): 51-57. ISSN0928-8244. PMID8821398.
Chihara, G (1992). «Recent progress in immunopharmacology and therapeutic effects of polysaccharides». Developments in biological standardization (Switzerland: Karger) 77: 191-197. ISSN0301-5149. PMID1426662.
DiLuzio, NR; Williams DL, McNamee RB, Malshet VG (1980). «Comparative evaluation of the tumor inhibitory and antibacterial activity of solubilized and particulate glucan». Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer (Germany: Springer Verlag) 75: 165-172. ISSN0080-0015. PMID7232829.
Wakui, A; Kasai M, Konno K, Abe R, Kanamaru R, Takahashi K, Nakai Y, Yoshida Y, Koie H, Masuda H, et al. (abril de 1986). «Randomized study of lentinan on patients with advanced gastric and colorectal cancer. Tohoku Lentinan Study Group». Gan to kagaku ryoho. Cancer & chemotherapy(en japonés) (Japan: Gan To Kagaku Ryohosha) 13 (4 pt 1): 1050-1059. ISSN0385-0684. PMID3083785.
Hong, F; Yan J; Baran JT; Allendorf DJ; Hansen RD; Ostroff GR; Xing PX; Cheung NK et al. (15 de julio de 2004). «Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models». Journal of immunology (Baltimore, Md. : 1950) (United States: American Association of Immunologists) 173 (2): 797-806. ISSN0022-1767. PMID15240666.Se sugiere usar |número-autores= (ayuda)
Hong, F; Hansen RD; Yan J; Allendorf DJ; Baran JT; Ostroff GR; Ross GD (15 de diciembre de 2003). «Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells». Cancer research (United States: American Association for Cancer Research) 63 (24): 9023-9031. ISSN0008-5472. PMID14695221.
Thornton, BP; Vĕtvicka V, Pitman M, Goldman RC, Ross GD (1 de febrero de 1996). «Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18)». Journal of immunology (Baltimore, Md. : 1950) (United States: American Association of Immunologists) 156 (3): 1235-1246. ISSN0022-1767. PMID8558003.
Fujimoto, S (septiembre de 1989). «Clinical efficacies of schizophyllan (SPG) on advanced gastric cancer». Nippon Geka Gakkai Zasshi(en japonés) (Japan: Nippon Geka Gakkai) 90 (9): 1447-1450. ISSN0301-4894. PMID2531270.
Hanaue, H; Tokuda Y, Machimura T, Kamijoh A, Kondo Y, Ogoshi K, Makuuchi H, Nakasaki H, Tajima T, Mitomi T, et al. (Sep-octubre de 1989). «Effects of oral lentinan on T-cell subsets in peripheral venous blood.». Clinical therapeutics (United States: Excerpta Medica) 11 (5): 614-622. ISSN0149-2918. PMID2529966.
Babineau, TJ; Hackford A; Kenler A; Bistrian B; Forse RA; Fairchild PG; Heard S; Keroack M; Caushaj P; Benotti P (noviembre de 1994). «A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients». Archives of surgery (Chicago, Ill. : 1960) (United States: American Medical Association) 129 (11): 1204-1210. ISSN0004-0010. PMID7979954.
Patchen, ML; DiLuzio NR, Jacques P, MacVittie TJ (diciembre de 1984). «Soluble polyglycans enhance recovery from cobalt-60--induced hemopoietic injury». Journal of biological response modifiers (United States: Raven Press) 3 (6): 627-633. ISSN0732-6580. PMID6512563.
Petruczenko, A (mayo-junio de 1984). «Glucan effect on the survival of mice after radiation exposure». Acta physiologica Polonica (Poland: Panstwowy Zaklad Wydawnictw Lekarskich) 35 (3): 231-236. ISSN0044-6033. PMID6537716.
Patchen, ML; MacVittie TJ (febrero de 1986). «Comparative effects of soluble and particulate glucans on survival in irradiated mice». Journal of biological response modifiers (EE.UU.: Raven Press) 5 (1): 45-60. ISSN0732-6580. PMID3958754.
Patchen, ML; Vaudrain T; Correira H; Martin T; Reese D (diciembre de 1998). «In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan.». Experimental hematology (Netherlands: Elsevier Science) 26 (13): 1247-1254. ISSN0301-472X. PMID9845381.
Tomoda, M; Ohara N; Shimizu N; Gonda R (marzo de 1994). «Characterization of a novel glucan, which exhibits reticuloendothelial system-potentiating and anti-complementary activities, from the rhizome of Cnidium officinale». Chemical & pharmaceutical bulletin (Japan: Pharmaceutical Society of Japan) 42 (3): 630-633. ISSN0009-2363. PMID8004712.
Kirmaz, C; Bayrak P; Yilmaz O; Yuksel H. (junio de 2005). «Effects of glucan treatment on the Th1/Th2 balance in patients with allergic rhinitis: a double-blind placebo-controlled study.». European cytokine network (France: John Libbey Eurotext) 16 (2): 128-134. ISSN1148-5493. PMID15941684.
Ooi VE, Liu F (July 2000). «Immunomodulation and anti-cancer activity of polysaccharide-protein complexes». Curr. Med. Chem.7 (7): 715-29. PMID10702635.
Wasser, SP; Weis AL (1999). «Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective». Critical reviews in immunology (United States: Begell House) 19 (1): 65-96. ISSN1040-8401. PMID9987601.
Miura, NN; Ohno N; Aketagawa J; Tamura H; Tanaka S; Yadomae T (enero de 1996). «Blood clearance of (1-->3)-beta-D-glucan in MRL lpr/lpr mice». FEMS immunology and medical microbiology (England: Blackwell Publishing) 13 (1): 51-57. ISSN0928-8244. PMID8821398.
Vetvicka, V; Thornton BP; Ross GD (1 de julio de 1996). «Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells». The Journal of clinical investigation (United States: American Society for Clinical Investigation) 98 (1): 50-61. PMID8690804. doi:10.1172/JCI118777.
Chihara, G (1992). «Recent progress in immunopharmacology and therapeutic effects of polysaccharides». Developments in biological standardization (Switzerland: Karger) 77: 191-197. ISSN0301-5149. PMID1426662.
DiLuzio, NR; Williams DL, McNamee RB, Malshet VG (1980). «Comparative evaluation of the tumor inhibitory and antibacterial activity of solubilized and particulate glucan». Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer (Germany: Springer Verlag) 75: 165-172. ISSN0080-0015. PMID7232829.
Sveinbjørnsson, B; Rushfeldt C, Seljelid R, Smedsrød B (mayo de 1998). «Inhibition of establishment and growth of mouse liver metastases after treatment with interferon gamma and beta-1,3-D-glucan». Hepatology (Baltimore, Md.) (United States: Wiley) 27 (5): 1241-1248. PMID9581677. doi:10.1002/hep.510270509.
Wakui, A; Kasai M, Konno K, Abe R, Kanamaru R, Takahashi K, Nakai Y, Yoshida Y, Koie H, Masuda H, et al. (abril de 1986). «Randomized study of lentinan on patients with advanced gastric and colorectal cancer. Tohoku Lentinan Study Group». Gan to kagaku ryoho. Cancer & chemotherapy(en japonés) (Japan: Gan To Kagaku Ryohosha) 13 (4 pt 1): 1050-1059. ISSN0385-0684. PMID3083785.
Hong, F; Yan J; Baran JT; Allendorf DJ; Hansen RD; Ostroff GR; Xing PX; Cheung NK et al. (15 de julio de 2004). «Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models». Journal of immunology (Baltimore, Md. : 1950) (United States: American Association of Immunologists) 173 (2): 797-806. ISSN0022-1767. PMID15240666.Se sugiere usar |número-autores= (ayuda)
Hong, F; Hansen RD; Yan J; Allendorf DJ; Baran JT; Ostroff GR; Ross GD (15 de diciembre de 2003). «Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells». Cancer research (United States: American Association for Cancer Research) 63 (24): 9023-9031. ISSN0008-5472. PMID14695221.
Thornton, BP; Vĕtvicka V, Pitman M, Goldman RC, Ross GD (1 de febrero de 1996). «Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18)». Journal of immunology (Baltimore, Md. : 1950) (United States: American Association of Immunologists) 156 (3): 1235-1246. ISSN0022-1767. PMID8558003.
Suzuki, I; Hashimoto K; Ohno N; Tanaka H; Yadomae T (1989). «Immunomodulation by orally administered beta-glucan in mice». >International journal of immunopharmacology (England: Elsevier Science) 11 (7): 761-769. PMID2599714. doi:10.1016/0192-0561(89)90130-6.
Demir, G; Klein HO, Mandel-Molinas N, Tuzuner N (enero de 2007). «Beta glucan induces proliferation and activation of monocytes in peripheral blood of patients with advanced breast cancer». International immunopharmacology (Netherlands: Elsevier Science) 7 (1): 113-116. PMID17161824. doi:10.1016/j.intimp.2006.08.011.
Babineau, TJ; Hackford A; Kenler A; Bistrian B; Forse RA; Fairchild PG; Heard S; Keroack M; Caushaj P; Benotti P (noviembre de 1994). «A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients». Archives of surgery (Chicago, Ill. : 1960) (United States: American Medical Association) 129 (11): 1204-1210. ISSN0004-0010. PMID7979954.
Dellinger, EP; Babineau TJ; Bleicher P; Kaiser AB; Seibert GB; Postier RG; Vogel SB; Norman J; Kaufman D; Galandiuk S; Condon RE (septiembre de 1999). «Effect of PGG-glucan on the rate of serious postoperative infection or death observed after high-risk gastrointestinal operations. Betafectin Gastrointestinal Study Group». Archives of surgery (Chicago, Ill. : 1960) (United States: American Medical Association) 134 (9): 977-983. PMID10487593. doi:10.1001/archsurg.134.9.977.
Patchen, ML; MacVittie TJ (abril de 1983). «Dose-dependent responses of murine pluripotent stem cells and myeloid and erythroid progenitor cells following administration of the immunomodulating agent glucan». Immunopharmacology (Netherlands: Elsevier/North-Holland) 5 (4): 303-313. PMID6853144. doi:10.1016/0162-3109(83)90046-2.
Patchen, ML; DiLuzio NR, Jacques P, MacVittie TJ (diciembre de 1984). «Soluble polyglycans enhance recovery from cobalt-60--induced hemopoietic injury». Journal of biological response modifiers (United States: Raven Press) 3 (6): 627-633. ISSN0732-6580. PMID6512563.
Patchen, ML; MacVittie TJ, Wathen LM (15 de noviembre de 1984). «Effects of pre- and post-irradiation glucan treatment on pluripotent stem cells, granulocyte, macrophage and erythroid progenitor cells, and hemopoietic stromal cells». Experientia (Switzerland: Birkhäuser Verlag) 40 (11): 1240-1244. PMID6500009. doi:10.1007/BF01946654.
Petruczenko, A (mayo-junio de 1984). «Glucan effect on the survival of mice after radiation exposure». Acta physiologica Polonica (Poland: Panstwowy Zaklad Wydawnictw Lekarskich) 35 (3): 231-236. ISSN0044-6033. PMID6537716.
Patchen, ML; MacVittie TJ (febrero de 1986). «Comparative effects of soluble and particulate glucans on survival in irradiated mice». Journal of biological response modifiers (EE.UU.: Raven Press) 5 (1): 45-60. ISSN0732-6580. PMID3958754.
Patchen, ML; Vaudrain T; Correira H; Martin T; Reese D (diciembre de 1998). «In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan.». Experimental hematology (Netherlands: Elsevier Science) 26 (13): 1247-1254. ISSN0301-472X. PMID9845381.
Turnbull, JL; Patchen ML; Scadden DT (1999). «The polysaccharide, PGG-glucan, enhances human myelopoiesis by direct action independent of and additive to early-acting cytokines». Acta haematologica (Switzerland: Karger) 102 (2): 66-71. PMID10529508. doi:10.1159/000040972.
Tomoda, M; Ohara N; Shimizu N; Gonda R (marzo de 1994). «Characterization of a novel glucan, which exhibits reticuloendothelial system-potentiating and anti-complementary activities, from the rhizome of Cnidium officinale». Chemical & pharmaceutical bulletin (Japan: Pharmaceutical Society of Japan) 42 (3): 630-633. ISSN0009-2363. PMID8004712.
Vetvicka, V; Dvorak B; Vetvickova J; Richter J; Krizan J; Sima P; Yvin JC (10 de marzo de 2007). «Orally administered marine (1-->3)-beta-D-glucan Phycarine stimulates both humoral and cellular immunity.». International journal of biological macromolecules (England: Butterworth-Heinemann) 40 (4): 291-298. PMID16978690. doi:10.1016/j.ijbiomac.2006.08.009.
Mucksová, J; Babícek K, Pospísil M (2001). «Particulate 1,3-beta-D-glucan, carboxymethylglucan and sulfoethylglucan--influence of their oral or intraperitoneal administration on immunological respondence of mice.». Folia microbiologica (Czech Republic: Slovak Academy Of Sciences) 46 (6): 559-563. PMID11898349. doi:10.1007/BF02818003.
Cramer, DE; Allendorf DJ; Baran JT; Hansen R; Marroquin J; Li B; Ratajczak J; Ratajczak MZ et al. (15 de enero de 2006). «Beta-glucan enhances complement-mediated hematopoietic recovery after bone marrow injury». Blood (United States: American Society of Hematology) 107 (2): 835-840. PMID16179370. doi:10.1182/blood-2005-07-2705.Se sugiere usar |número-autores= (ayuda)
Sener, G; Toklu H; Ercan F; Erkanli G (agosto de 2005). «Protective effect of beta-glucan against oxidative organ injury in a rat model of sepsis». International immunopharmacology (Netherlands: Elsevier Science) 5 (9): 1387-1396. PMID15953565. doi:10.1016/j.intimp.2005.03.007.
Browder, IW; Williams DL, Kitahama A, Di Luzio NR (1984). «Modification of post-operative C. albicans sepsis by glucan immunostimulation.». International journal of immunopharmacology (England: Elsevier Science) 6 (1): 19-26. PMID6724765. doi:10.1016/0192-0561(84)90030-4.
Kirmaz, C; Bayrak P; Yilmaz O; Yuksel H. (junio de 2005). «Effects of glucan treatment on the Th1/Th2 balance in patients with allergic rhinitis: a double-blind placebo-controlled study.». European cytokine network (France: John Libbey Eurotext) 16 (2): 128-134. ISSN1148-5493. PMID15941684.
Bolcal, C; Bolcal C, Yildirim V, Doganci S, Sargin M, Aydin A, Eken A, Ozal E, Kuralay E, Demirkilic U, Tatar H (15 de mayo de 2007). «Protective effects of antioxidant medications on limb ischemia reperfusion injury». The Journal of surgical research (United States: Academic Press) 139 (2): 274-279. PMID17349658. doi:10.1016/j.jss.2006.10.043.
Frey, A.; Frey A, Giannasca KT, Weltzin R, Giannasca PJ, Reggio H, Lencer WI, Neutra MR (1 de septiembre de 1996). «Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting». The Journal of experimental medicine (United States: Rockefeller University Press) 184 (3): 1045-1059. PMID9064322. doi:10.1084/jem.184.3.1045.
Tsukagoshi, S; Tsukagoshi S, Hashimoto Y, Fujii G, Kobayashi H, Nomoto K, Orita K (junio de 1984). «Krestin (PSK)». Cancer treatment reviews (England: Saunders) 11 (2): 131-155. PMID6238674. doi:10.1016/0305-7372(84)90005-7.